Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial by Infante, Jeffrey R, Dr, Fecher, Leslie A, MD, Falchook, Gerald S, MD, Nallapareddy, Sujatha, MD, Gordon, Michael S, MD, Becerra, Carlos, MD, DeMarini, Douglas J, PhD, Cox, Donna S, PhD, Xu, Yanmei, MS, Morris, Shannon R, MD, Peddareddigari, Vijay GR, MD, Le, Ngocdiep T, MD, Hart, Lowell, MD, Bendell, Johanna C, MD, Eckhardt, Gail, MD, Kurzrock, Razelle, Prof, Flaherty, Keith, MD, Burris, Howard A, MD, Messersmith, Wells A, MD

Get full text

Patient-Reported Outcomes as a Component of the Primary Endpoint in a Double-Blind, Placebo-Controlled Trial in Advanced Pancreatic Cancer by Eckhardt, S. Gail, MD, De Porre, Peter, MD, Smith, David, MD, Maurel, Joan, MD, Steward, William P., MD, Bouche, Olivier, MD, van de Velde, Helgi, MD, Michiels, Bart, PhD, Bugat, Roland, MD

Get full text

Targeted manipulation of apoptosis in cancer treatment by Call, Justin A, MD, Eckhardt, S Gail, Prof, Camidge, D Ross, Dr

Get full text